Skip to main content
. Author manuscript; available in PMC: 2022 Mar 7.
Published in final edited form as: Clin Cancer Res. 2021 Jun 1;27(14):4025–4035. doi: 10.1158/1078-0432.CCR-21-0575

Figure 3. Survival outcomes of urothelial carcinoma patient according to CDKN2A GAs, not treated with ICI therapy.

Figure 3.

A. Overall survival of DFCI platinum-treated mUC cohort. B. Overall survival of TCGA mUC patients. C. Progression-free survival in TCGA mUC patients.